| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027178 |
| Receipt No. | R000031141 |
| Official scientific title of the study | Comprehensive study on the health promotion effect by continuous ingestion of peanuts for 8 weeks |
| Date of disclosure of the study information | 2017/04/28 |
| Last modified on | 2017/07/25 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Comprehensive study on the health promotion effect by continuous ingestion of peanuts for 8 weeks | |
| Title of the study (Brief title) | Comprehensive study on the health promotion effect by continuous ingestion of peanuts for 8 weeks | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Examine comprehensively about the health promotion effect of continuous ingestion of peanuts against healthy adult women. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Obesity related factor |
| Key secondary outcomes | Self-aware questionnaire, blood test (general biochemical test), blood oxidative stress marker, blood glycation marker, urine putrid substance, intestinal flora |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingest peanuts 27.5 g/day for 8 continuous weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2. Healthy Japanese women who is 30 years old or more and less than 60 years old 3. Persons whose BMI is 23 or more |
|||
| Key exclusion criteria | 1. Persons with the severe disease medical history
2. Persons who are allergic to the test food 3. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 4. Persons who are pregnant, breastfeeding, planning or hoping to be pregnant during the study period 5. Persons who were judged as inappropriate for subjects by the principal investigator |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Toshihiko Osawa |
| Organization | Aichi Gakuin University |
| Division name | Department of Health and Nutrition |
| Address | 12 Araike, Iwasaki-cho, Nisshin-shi, Aichi, Japan |
| TEL | 0561-73-1111 |
| osawat@dpc.aichi-gakuin.ac.jp | |
| Public contact | |
| Name of contact person | Hirohito Ishikawa |
| Organization | Healthcare Systems Co., Ltd. |
| Division name | Research and Development |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 03-6809-2722 |
| Homepage URL | |
| ishikawa@hc-sys.jp | |
| Sponsor | |
| Institute | Denroku Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Denroku Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Healthcare Systems Co., Ltd.
Aichi Gakuin University |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031141 |